Načítá se...
Warfarin: The End or the End of One Size Fits All Therapy?
Oral anticoagulants are required for both treatment and prophylaxis in many different diseases. Clinicians and patients now have a choice of oral anticoagulants, including the vitamin K antagonists (of which warfarin is the most widely used and is used as the exemplar in this paper), and direct oral...
Uloženo v:
| Vydáno v: | J Pers Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163581/ https://ncbi.nlm.nih.gov/pubmed/29958440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm8030022 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|